BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11248670)

  • 1. Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism.
    Grant P; Sharma P; Pant HC
    Eur J Biochem; 2001 Mar; 268(6):1534-46. PubMed ID: 11248670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.
    Hallows JL; Chen K; DePinho RA; Vincent I
    J Neurosci; 2003 Nov; 23(33):10633-44. PubMed ID: 14627648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.
    Maccioni RB; Otth C; Concha II; Muñoz JP
    Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cyclin-dependent kinase 5 and its activator P35 in local axon and growth cone stabilization.
    Hahn CM; Kleinholz H; Koester MP; Grieser S; Thelen K; Pollerberg GE
    Neuroscience; 2005; 134(2):449-65. PubMed ID: 15964697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinase 5 in neurofilament function and regulation.
    Kesavapany S; Li BS; Pant HC
    Neurosignals; 2003; 12(4-5):252-64. PubMed ID: 14673212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-protein interactions in Cdk5 regulation and function.
    Lim AC; Qu D; Qi RZ
    Neurosignals; 2003; 12(4-5):230-8. PubMed ID: 14673210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction.
    Kesavapany S; Lau KF; McLoughlin DM; Brownlees J; Ackerley S; Leigh PN; Shaw CE; Miller CC
    Eur J Neurosci; 2001 Jan; 13(2):241-7. PubMed ID: 11168528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model.
    Bu B; Li J; Davies P; Vincent I
    J Neurosci; 2002 Aug; 22(15):6515-25. PubMed ID: 12151531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdk5 regulates axonal transport and phosphorylation of neurofilaments in cultured neurons.
    Shea TB; Yabe JT; Ortiz D; Pimenta A; Loomis P; Goldman RD; Amin N; Pant HC
    J Cell Sci; 2004 Feb; 117(Pt 6):933-41. PubMed ID: 14762105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses.
    Johansson JU; Lilja L; Chen XL; Higashida H; Meister B; Noda M; Zhong ZG; Yokoyama S; Berggren PO; Bark C
    Brain Res Mol Brain Res; 2005 Aug; 138(2):215-27. PubMed ID: 15908038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of human high molecular weight neurofilament protein (hNF-H) by neuronal cyclin-dependent kinase 5 (cdk5).
    Pant AC; Veeranna ; Pant HC; Amin N
    Brain Res; 1997 Aug; 765(2):259-66. PubMed ID: 9313898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.
    Ohshima T; Ward JM; Huh CG; Longenecker G; Veeranna ; Pant HC; Brady RO; Martin LJ; Kulkarni AB
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11173-8. PubMed ID: 8855328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
    Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
    J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.
    Ko J; Humbert S; Bronson RT; Takahashi S; Kulkarni AB; Li E; Tsai LH
    J Neurosci; 2001 Sep; 21(17):6758-71. PubMed ID: 11517264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.
    Kesavapany S; Li BS; Amin N; Zheng YL; Grant P; Pant HC
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):143-53. PubMed ID: 15023357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclin-dependent kinase Cdk5 controls multiple aspects of axon patterning in vivo.
    Connell-Crowley L; Le Gall M; Vo DJ; Giniger E
    Curr Biol; 2000 May; 10(10):599-602. PubMed ID: 10837225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity.
    Nikolic M; Chou MM; Lu W; Mayer BJ; Tsai LH
    Nature; 1998 Sep; 395(6698):194-8. PubMed ID: 9744280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
    Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
    Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of the high molecular weight neurofilament protein (NF-H) by Cdk5 and p35.
    Sun D; Leung CL; Liem RK
    J Biol Chem; 1996 Jun; 271(24):14245-51. PubMed ID: 8662984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.